1. Home
  2. DERM vs III Comparison

DERM vs III Comparison

Compare DERM & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • III
  • Stock Information
  • Founded
  • DERM 2014
  • III 2006
  • Country
  • DERM United States
  • III United States
  • Employees
  • DERM N/A
  • III N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • III Professional Services
  • Sector
  • DERM Health Care
  • III Consumer Discretionary
  • Exchange
  • DERM Nasdaq
  • III Nasdaq
  • Market Cap
  • DERM 174.7M
  • III 171.3M
  • IPO Year
  • DERM 2021
  • III 2007
  • Fundamental
  • Price
  • DERM $6.88
  • III $4.64
  • Analyst Decision
  • DERM Strong Buy
  • III Buy
  • Analyst Count
  • DERM 2
  • III 1
  • Target Price
  • DERM $10.00
  • III $3.75
  • AVG Volume (30 Days)
  • DERM 78.2K
  • III 116.6K
  • Earning Date
  • DERM 05-20-2025
  • III 05-08-2025
  • Dividend Yield
  • DERM N/A
  • III 3.95%
  • EPS Growth
  • DERM N/A
  • III N/A
  • EPS
  • DERM N/A
  • III 0.16
  • Revenue
  • DERM $56,134,000.00
  • III $242,899,000.00
  • Revenue This Year
  • DERM $29.83
  • III N/A
  • Revenue Next Year
  • DERM $54.88
  • III $5.20
  • P/E Ratio
  • DERM N/A
  • III $29.12
  • Revenue Growth
  • DERM N/A
  • III N/A
  • 52 Week Low
  • DERM $3.20
  • III $2.92
  • 52 Week High
  • DERM $7.84
  • III $4.05
  • Technical
  • Relative Strength Index (RSI)
  • DERM 52.73
  • III 79.29
  • Support Level
  • DERM $6.47
  • III $3.89
  • Resistance Level
  • DERM $7.15
  • III $4.03
  • Average True Range (ATR)
  • DERM 0.49
  • III 0.17
  • MACD
  • DERM -0.09
  • III 0.06
  • Stochastic Oscillator
  • DERM 37.25
  • III 96.40

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About III Information Services Group Inc.

Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.

Share on Social Networks: